Questions for the Harvard case “Metabical: Pricing‚ Packaging‚ and Demand Forecasting for a New Weight-Loss Drug” For March 20‚ write responses to the following questions for the Metabical case. 1) How is Metabical different from the existing weight-loss options? How is it better or worse than the other options? Metabical is the first prescription drug approved specifically for overweight individuals (BMI between 25 and 30)‚ those individuals who have weight-loss goals of approximately
Premium Obesity Weight loss Nutrition
Hello Metabical Positioning And Communications Strategy For a New Weight Loss Drug Harvard Business Essays and Term Papers Search Results for ’metabical positioning and communications strategy for a new weight loss drug harvard business ’ Displaying 1 - 30 of 1‚500 * Metabical: Positioning And Communications Strategy For a New Weight-Loss Drug Metabical: Positioning and Communications Strategy for a new Weight-Loss Drug Q & A 1. Who is involved in the decision making process? What
Premium Marketing Weight loss
1. 1. EXECUTIVE SUMMARY 5 2. A. THE BUSINESS 5 3. B. THE STRATEGY 5 4. C. THE MARKET 6 5. D. THE MANAGEMENT 6 6. E. THE FINANCIALS 7 7. F. THE COMPANY MISSION 7 8. G. THE CRITERIA OF MVNO 8 9. H. EXCEPTIONS 8 10. 2. THE BUSINESS 9 11. A. REQUIREMENT ANALYSIS 9 12. B. DESCRIPTION OF SERVICES 9 13. C. TARGET MARKET 10 14. D. SERVICES OFFERED – PRIMARY REVENUE DRIVERS 11 15. E. POTENTIAL FUTURE SERVICES – ALTERNATIVE REVENUE SOURCES 12 16. F. DISTRIBUTION‚ PURCHASING AND REFILLS 17
Premium Customer service Mobile phone Mobile network operator
* Weight-loss drugs Market before Metabical * Prevailing Safety Concerns; limiting options for patients * No prescription-drug option for the overweight segment (BMI 25-30) * Many OTC drugs available for patients with BMI 30+ including FDA-approved ‘Alli’ but various negative side effects reported‚ e.g.‚ 30 liver damage cases in Alli & Xenical during ‘99-‘08 * Other solutions categorized as herbal or dietary supplements were not regulated by the FDA i.e.‚ safety not warranted
Premium Obesity Medicine Weight loss
1. What makes Metabical different from the other weight-loss products on the market? Medibical is the first FDA-approved prescription drug for the overweight segment (BMI 25-30). It is a low-dose formula that reduces stress on heart and liver functions. Metabical also contains a controlled-release feature that requires only one pill be taken per day which leads to better patient compliance. Participants experience dramatic weight loss with an average 26 pounds for BMI 28-30 and 15 pounds for BMI
Premium Obesity Nutrition Dieting
INDIVIDUAL CASE STUDY METABICAL: _POSITIONING & COMMUNICATIONS STRATEGY_ _FOR A NEW WEIGHT-LOSS DRUG_ Q1: WHAT IS THE DECISION-MAKING PROCESS FOR METABICAL? WHO IS INVOLVED IN THE PROCESS? Consumer research over the years has shown that shoppers often follow a relatively common shopping behavior for product purchase. In theory‚ a shopper is said to go through the following five stages as a process. In reality‚ sometimes the steps may be switched around or even left out‚ as not all consumers
Premium Obesity Medicine Weight loss
1. What is the decision-making process for Metabical? Who is involved in the process? Market research: investigating into the overall adult overweight situation in U.S. fand overweight population and consumers’ perception of the currently existed weight-loss drugs. Analyzing differential advantages: CSP should recognize the Metabical’s competitive factors first. Metabical is the first prescription drug approved by FDA and has less negative side effect and can magically loss weight. Recognizing
Premium Obesity Weight loss Health
Apparently it’s Printup the senior director of marketing who is assigned the task to make decisions about Metabical. These decisions about Metabical will decide the fate of the drug. If it is observed closely there are many other stakeholders involved that will eventually decide about the fate of this drug. Printup would decide the marketing and public relation strategies to push the drug in the market. But it’s FDA that’s quite active and concerned after few awful events which occurred from usage
Premium Marketing Decision making
Overview Quelch and Beckham present a break down of the weight-loss product called “Metabical”. Quelch and Beckham show that “Metabicals” optimal target customer are Over Weight United States demographic. Premises “Excess weight is considered a public health crisis in the U.S.‚ with approximately 65% of the entire adult population categorized as overweight‚ obese‚ or severely obese.” True This premises supports the claim the question presents in showing evidence that authors of the case
Premium Obesity Hypertension Cancer
Answer 1 - Each customer will need to answer the following questions: 1. Am I obese . One needs to analyze BMI data for finding an answer to this. 2. Do I want to change The answer to this question depends upon the following criteria. 1. Looks consciousness 2. Health consciousness 3. If the answer to both the above questions is yes then there will be 3 options for the customer for Exercise | OTC | Prescribed drugs | Pros1. Healthy@ naturalGood habitLifestyleCons:Time consuming
Premium Health care Health Health insurance